Reliability and validity of the Japanese version of the Ocular Surface Disease Index for dry eye disease.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
25 11 2019
Historique:
entrez: 28 11 2019
pubmed: 28 11 2019
medline: 20 11 2020
Statut: epublish

Résumé

The Ocular Surface Disease Index (OSDI) questionnaire is widely used to evaluate subjective symptoms of dry eye disease (DED) as a primary diagnostic criterion. This study aimed to develop a Japanese version of the OSDI (J-OSDI) and assess its reliability and validity. Hospital-based cross-sectional observational study. A total of 209 patients recruited from the Department of Ophthalmology at Juntendo University Hospital. We translated and culturally adapted the OSDI into Japanese. The J-OSDI was then assessed for internal consistency, reliability and validity. We also evaluated the optimal cut-off value to suspect DED using an area under the receiver operating characteristic curve (AUC) analysis. Internal consistency, test-retest reliability and discriminant validity of the J-OSDI as well as the optimal cut-off value to suspect DED. Of the participants, 152 had DED and 57 did not. The J-OSDI total score showed good internal consistency (Cronbach's alpha=0.884), test-retest reliability (interclass correlation coefficient=0.910) and discriminant validity by known-group comparisons (non-DED, 19.4±16.0; DED, 37.7±22.2; p<0.001). Factor validity was used to confirm three subscales within the J-OSDI according to the original version of the questionnaire. Concurrent validity was assessed by Pearson correlation analysis, and the J-OSDI total score showed a strong positive correlation with the Dry Eye-Related Quality-of-Life Score (γ=0.829). The optimal cut-off value of the J-OSDI total score was 36.3 (AUC=0.744). The J-OSDI was developed and validated in terms of reliability and validity as an effective tool for DED assessment and monitoring in the Japanese population.

Identifiants

pubmed: 31772113
pii: bmjopen-2019-033940
doi: 10.1136/bmjopen-2019-033940
pmc: PMC6886996
doi:

Types de publication

Journal Article Observational Study Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e033940

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Pers Assess. 2003 Feb;80(1):99-103
pubmed: 12584072
Health Qual Life Outcomes. 2017 Jul 17;15(1):145
pubmed: 28716084
Ophthalmology. 2019 May;126(5):766-768
pubmed: 30550734
PLoS One. 2014 May 21;9(5):e97921
pubmed: 24848115
CLAO J. 1995 Oct;21(4):221-32
pubmed: 8565190
Ocul Surf. 2017 Jul;15(3):334-365
pubmed: 28736337
J Clin Epidemiol. 1993 Dec;46(12):1417-32
pubmed: 8263569
Cornea. 1996 May;15(3):235-9
pubmed: 8713924
Arch Ophthalmol. 1969 Jul;82(1):10-4
pubmed: 4183019
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91
pubmed: 11124735
Arq Bras Oftalmol. 2017 Jan-Feb;80(1):14-16
pubmed: 28380095
Ann Rheum Dis. 1998 Jan;57(1):20-4
pubmed: 9536818
J Ophthalmic Vis Res. 2017 Jul-Sep;12(3):301-304
pubmed: 28791064
Cornea. 2011 Apr;30(4):379-87
pubmed: 21045640
Ocul Surf. 2007 Apr;5(2):75-92
pubmed: 17508116
J Clin Epidemiol. 2015 Apr;68(4):370-8
pubmed: 25619561
Am J Ophthalmol. 2014 Feb;157(2):294-300
pubmed: 24184225
Ocul Surf. 2017 Jul;15(3):539-574
pubmed: 28736342
Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2341-5
pubmed: 15980220
Control Clin Trials. 1991 Aug;12(4 Suppl):142S-158S
pubmed: 1663851
Arch Ophthalmol. 2000 May;118(5):615-21
pubmed: 10815152
J Clin Epidemiol. 2003 Aug;56(8):730-5
pubmed: 12954464
JAMA Ophthalmol. 2013 Oct;131(10):1331-8
pubmed: 23949096
Sci Rep. 2018 Jan 30;8(1):1918
pubmed: 29382858
J Clin Med. 2019 Sep 11;8(9):null
pubmed: 31514344
Ocul Surf. 2017 Jan;15(1):65-76
pubmed: 27725302
Cornea. 2015 Oct;34(10):1221-6
pubmed: 26266432
Sci Rep. 2018 Sep 7;8(1):13443
pubmed: 30194447

Auteurs

Akie Midorikawa-Inomata (A)

Department of Hospital Administration, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.

Takenori Inomata (T)

Department of Hospital Administration, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan tinoma@juntendo.ac.jp.
Department of Ophthalmology, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan.
Department of Strategic Operating Room Management and Improvement, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan.

Shuko Nojiri (S)

Department of Medical Technology Center, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan.

Masahiro Nakamura (M)

Precision Health, Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.

Masao Iwagami (M)

Department of Health Services Research, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Keiichi Fujimoto (K)

Department of Ophthalmology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.

Yuichi Okumura (Y)

Department of Strategic Operating Room Management and Improvement, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan.
Department of Ophthalmology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.

Nanami Iwata (N)

Department of Ophthalmology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.

Atsuko Eguchi (A)

Department of Hospital Administration, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.

Hitomi Hasegawa (H)

Department of Ophthalmology, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan.

Hikaru Kinouchi (H)

School of Cultural and Creative Studies, Aoyama Gakuin University, Shibuya-ku, Tokyo, Japan.

Akira Murakami (A)

Department of Ophthalmology, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan.

Hiroyuki Kobayashi (H)

Department of Hospital Administration, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH